1-(9H-Pyrido[3,4-b]indol-1-yl)-1,4-butanediol

Metabolite details

Identifier

SPYBYBYFMPTBMD-UHFFFAOYSA-N

InChI Key

SPYBYBYFMPTBMD-UHFFFAOYSA-N

IUPAC name

1-(9H-pyrido[3,4-b]indol-1-yl)butane-1,4-diol

Preferred name

1-(9H-Pyrido[3,4-b]indol-1-yl)-1,4-butanediol

INN name

—

Synonym

—

ChEBI

CHEBI:172497

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
• Multi-Omics Analysis Reveals Disturbance of Nanosecond Pulsed Electric Field in the Serum Metabolic Spectrum and Gut Microbiota
• Diallyl disulfide (DADS) ameliorates intestinal Candida albicans infection by modulating the gut microbiota and metabolites and providing intestinal protection in mice
• Mechanism of interventional effect and targets of Zhuyu Pill in regulating and suppressing colitis and cholestasis
• Comparative metabolomic analysis of exudates of microcystin-producing and microcystin-free Microcystis aeruginosa strains
• PatA mediates biofilm formation and drugs resistance through regulating the synthesis of glycolipids and lipids in mycobacterium PatA mediates a novel mycolic acid synthesis pathway and regulates biofilm formation in mycobacterium

Observed in differential profiles

• G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
• Control_vs_nsPEF_7_day
• G1_PBS_vs_G2_DSS
• Control_vs_ZYP_High_Dose
• MC-producing_Exponential_vs_MC-free_Exponential
• wild_type_vs_patA_deletion